Short interest in Inhibikase Therapeutics Inc (NASDAQ:IKT) increased during the last reporting period, rising from 45.80K to 61.01K. This put 0.96% of the company's publicly available shares short.

Short interest for Inhibikase Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Inhibikase Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 30.00K shares traded per day, it would take 2.03 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.